Published in Exp Neurol on November 01, 2003
"Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A (2010) 2.50
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm (Vienna) (2010) 1.66
Physical activities and future risk of Parkinson disease. Neurology (2010) 1.42
Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Front Neurol (2011) 1.41
Treatment of Parkinson's disease with trophic factors. Neurotherapeutics (2008) 1.35
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol (2013) 1.30
Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur J Neurosci (2011) 1.24
Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study. J Gerontol A Biol Sci Med Sci (2009) 1.24
Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease. Eur J Neurosci (2008) 1.24
Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol (2008) 1.13
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J (2006) 1.09
Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res (2010) 1.05
Running and addiction: precipitated withdrawal in a rat model of activity-based anorexia. Behav Neurosci (2009) 0.99
Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci (2012) 0.96
Asymmetry and freezing of gait in parkinsonian patients. J Neurol (2012) 0.91
Running wheel activity restores MPTP-induced functional deficits. J Neural Transm (Vienna) (2010) 0.90
Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease. J Commun Disord (2011) 0.90
An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus. Int J Pept (2011) 0.88
Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res (2010) 0.88
Treadmill exercise induces hippocampal astroglial alterations in rats. Neural Plast (2013) 0.87
Exercise benefits brain function: the monoamine connection. Brain Sci (2013) 0.83
May exercise prevent addiction? Curr Neuropharmacol (2011) 0.82
The effect of age and tongue exercise on BDNF and TrkB in the hypoglossal nucleus of rats. Behav Brain Res (2011) 0.82
Exercise alters resting-state functional connectivity of motor circuits in parkinsonian rats. Neurobiol Aging (2014) 0.81
Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines. PLoS Curr (2010) 0.80
Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res (2013) 0.80
Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson's Disease: A Systematic Review. Behav Neurol (2015) 0.79
An evidence-based exercise regimen for patients with mild to moderate Parkinson's disease. Brain Sci (2013) 0.79
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses. Front Comput Neurosci (2013) 0.78
Impact of exercise on mitochondrial transcription factor expression and damage in the striatum of a chronic mouse model of Parkinson's disease. Neurosci Lett (2011) 0.77
Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats. ACS Chem Neurosci (2015) 0.76
Improved infrared-sensing running wheel systems with an effective exercise activity indicator. PLoS One (2015) 0.75
Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease. Behav Brain Res (2016) 0.75
Habituation Training Improves Locomotor Performance in a Forced Running Wheel System in Rats. Front Behav Neurosci (2017) 0.75
Levodopa therapy from the neuroprotection viewpoint. From a clinical outlook. J Neurol (2005) 0.75
Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol (2003) 1.85
Neurobiology of exercise. Obesity (Silver Spring) (2006) 3.39
A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci (2002) 2.37
The essential nature of sharing in science. Sci Eng Ethics (2010) 1.87
Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem (2003) 1.53
Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci (2002) 1.40
Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis (2008) 1.29
Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol (2011) 1.14
Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J Neurochem (2004) 1.14
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem (2007) 1.12
Stress-induced Parkinson's disease: a working hypothesis. Physiol Behav (2002) 1.08
Helping students get into graduate school. J Undergrad Neurosci Educ (2004) 1.06
Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J Neurosci Res (2008) 1.04
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res (2006) 1.04
Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res (2003) 1.03
Educational approaches for discouraging plagiarism. Urol Oncol (2011) 0.98
Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration. Brain Res (2010) 0.91
Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. J Neurochem (2006) 0.87
Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. J Neurosci Res (2008) 0.84
Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF. Brain Res Mol Brain Res (2005) 0.83
Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. J Neurochem (2008) 0.81
Assaying multiple biochemical variables from the same tissue sample. J Neurosci Methods (2010) 0.80
Gene transcripts associated with BMI in the motor cortex and caudate nucleus of calorie restricted rhesus monkeys. Genomics (2011) 0.79
[3H]Dopamine release in striatum in response to cortical stimulation in a corticostriatal slice preparation. J Neurosci Methods (2003) 0.78
Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study. PLoS One (2011) 0.78
Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Brain Res Mol Brain Res (2003) 0.78
Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures. J Neurosci Res (2014) 0.77
Physical activity-associated gene expression signature in nonhuman primate motor cortex. Obesity (Silver Spring) (2011) 0.77
L-DOPA reverses motor deficits associated with normal aging in mice. Neurosci Lett (2010) 0.77
The interaction between stress and exercise, and its impact on brain function. Metab Brain Dis (2014) 0.76
GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death. Front Biosci (Elite Ed) (2012) 0.76
Promoting responsible conduct: striving for change rather than consensus. Commentary on "Ambiguity, trust, and the responsible conduct of research" (F. Grinnell) Sci Eng Ethics (1999) 0.75